Articles written by Patricio Liddle - Benzinga

Cannabis REIT NewLake's Q1 2024 Revenue Grows 10.4% Hitting $12.6M, CEO Is Optimistic About Possible Marijuana Rescheduling

Explore NewLake Capital's Q1 earnings surge! Discover key financial highlights, operational moves and CEO's insights in the cannabis industry.

AFC Gamma Q1 2024 Reports Sharp YoY Net Income Drop Amid $90M Loan Expansion

AFC Gamma Q1 sees a net loss with $90M in loans made, amid significant industry movements. Read the financial highlights.

Cannabis Titan Cannabist: Q1 2024 Revenue Holds Steady At $122.6M, Trims Net Loss By 5% YoY

The Cannabist Company's Q1 2024 financial results: $122.6M revenue, $34.6M net loss. CEO David Hart outlines strategic initiatives for growth.

Legal Cannabis States Raked In $20B Since 2014, Peaking At $4B In 2023, New Report Shows

Explore how states with legal adult-use cannabis have generated over $20 billion in tax revenue, driving economic growth and job creation.

CBD-Focused Charlotte's Web Revenue Drops 29% In Q1 Amid Strategic Adjustments

Charlotte's Web reports a 29% revenue decline in Q1 2024, faces net loss, and plans strategic adjustments to boost operational efficiency.

Cannabis Enters CPG Era: Data, Brand And Market Strategies Explained By Industry Leaders At Benzinga Conference

Explore how cannabis is adopting CPG strategies to reshape the industry. Insights from Benzinga's panel on data-driven market success.

Net Income Dip: Cannabis REIT Chicago Atlantic's Q1 2024 Financial Results Breakdown

Get exclusive insights into Chicago Atlantic's Q1 2024 financial performance. Discover key metrics, trends, and management commentary.

Canopy Growth Expands U.S. Reach By Acquiring These Two Key Cannabis Brands

Canopy Growth confirms acquisitions of Wana and Jetty, enhancing its U.S. cannabis market strategy and operational synergies.

Divine Supply: How A California Church Became A Psychedelics And Weed Sanctuary Challenging Federal Prohibition

Explore how Dave Hodges' Church of Ambrosia challenges federal laws with spiritual uses of cannabis and psychedelics. Read now!

Hemp Advocates Rejoice As Senate Dems Push To Lift Felony Ban In 2024 Farm Bill Proposal

Explore the impact of Senate Dems and House GOP 2024 Farm Bill frameworks on the hemp industry. Key regulatory challenges examined.

Florida Ballot Battles: Voter Decision On Cannabis And Abortion Amendments Could Be Challenged By Lawmakers

Discover the impact of Florida's pivotal ballot amendments on cannabis and abortion rights, and the potential challenges from lawmakers.

This Real Estate Company Just Poured $8.5M Into A New York-Based Cannabis Operation

Rainbow Realty Group secures $8.5M acquisition loan for cannabis cultivation in Hudson Valley, expanding market-leading operation. Read now!

Revenue Down, Margins Up: Lifeist's Q1 Financial Results Show Focus On Premium Products Curbed Revenue Drop

Lifeist Wellness' Q1 2024 financial results, highlight a strategic shift towards higher-margin products and improved efficiencies. Read now!

Gov. Gavin Newsom Intensifies Scrutiny On Illegal Hemp Products, Calls To Safeguard Youth

Gov. Newsom directs action against illegal hemp in CA, seeking to ensure safety with strict labeling laws and penalties for non-compliance.

Hope For Those Going Up in Smoke: Cannabis Industry Eyes Bankruptcy Reform Amid Legal Limbo

Discover the latest on cannabis bankruptcy reform in the US. Learn how legal shifts and industry challenges are reshaping financial strategies.

How Cannabis Laws Impact Immigration: New Study Links State Legalization To Less Deportations

Discover research revealing the impact of cannabis legalization on immigration enforcement. Learn how laws shape deportation rates. Read now!

Massachusetts Cannabis Sales Soar Past $6B Record, Canada Sees Steady 1.7% Year-Over-Year Growth

Explore how Massachusetts hits a $6B cannabis sales record and Canada's market sees a steady 1.7% growth. Read more on regional sales trends.

Tryp Therapeutics Set To Finalize Merger With Exopharm, Announces Trading Halt Ahead Of ASX Listing

Tryp Therapeutics finalizes merger with Exopharm, prepares for ASX listing with strategic shareholder benefits. Explore merger details now!

New Name, Same Quality: Cannabis Vapor Tech Leader AVD Rebrands As ACTIVE

AVD rebrands as ACTIVE to reflect values and approach in the cannabis industry. CEO Alex Kwon comments on the rebranding. Read now!

NJ Activists Plant Cannabis Garden On State House Lawn, Fentanyl Replaces MDMA In Fed Drug Testing, Psychedelics Therapy For Vets

NJ activists defy laws with a cannabis garden, Congress advocates MDMA therapy for vets, and fentanyl replaces MDMA in federal tests. Read!